Solvay


Impairment-driven effects

25/06/20 -"We have factored in the potential c.€1.5bn impairment on the composites and (shale) oil & gas business, due to the subdued future business expectations. "

Pages
56
Language
English
Published on
25/06/20
You may also be interested by these reports :
10/07/20
BASF’s preliminary Q2 figures were characterised by a slightly better than expected operating and earnings performance before one-offs, but were hit ...

10/07/20
We still have not made up our minds and it will be quite challenging to come to a conclusion without additional information. Nevertheless, the ...

25/06/20
We have factored in the potential c.€1.5bn impairment on the composites and (shale) oil & gas business, due to the subdued future business ...

24/06/20
Solvay’s €1.5bn impairment of the back of the current challenging business situation is the price the current management has to pay for the ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO